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Randomised controlled trial of the Lidcombe programme of early
stuttering intervention
Mark Jones, Mark Onslow, Ann Packman, Shelley Williams, Tika Ormond, Ilsa Schwarz, Val Gebski
Abstract
Objectives To evaluate the efficacy of the Lidcombe
programme of early stuttering intervention by comparison to a
control group.
Design A pragmatic, open plan, parallel group, randomised
controlled trial with blinded outcome assessment.
Setting Two public speech clinics in New Zealand.
Participants Stuttering preschool children who presented to
the speech clinics for treatment. Inclusion criteria were age 3-6
years and frequency of stuttering of at least 2% syllables
stuttered. Exclusion criteria were onset of stuttering during the
six months before recruitment and treatment for stuttering
during the previous 12 months. 54 participants were
randomised: 29 to the Lidcombe programme arm and 25 to
the control arm. 12 of the participants were girls.
Intervention Lidcombe programme of early stuttering
intervention.
Main outcome measures Frequency of stuttering was
measured as the proportion of syllables stuttered, from
audiotaped recordings of participants’ conversational speech
outside the clinic. Parents in both arms of the trial collected
speech samples in three different speaking situations before
randomisation and at three, six, and nine months after
randomisation.
Results Analysis showed a highly significant difference
(P = 0.003) at nine months after randomisation. The mean
proportion of syllables stuttered at nine months after
randomisation was 1.5% (SD 1.4) for the treatment arm and
3.9% (SD 3.5) for the control arm, giving an effect size of 2.3%
of syllables stuttered (95% confidence interval 0.8 to 3.9). This
effect size was more than double the minimum clinically
worthwhile difference specified in the trial protocol.
Conclusions The results provide evidence from a randomised
controlled trial to support early intervention for stuttering. The
Lidcombe programme is an efficacious treatment for stuttering
in children of preschool age.
Introduction
Stuttering usually starts in the third and fourth years of life, after
a period of apparently normal speech development. Around 5%
of children begin to stutter.1 Although the recovery rate without
professional intervention is 74%,2 the natural recovery rate of
cases presenting to clinics has not been researched. To date, sex
and family history of recovery are the major identified predictors
of natural recovery. Girls are more likely to recover than boys,
and children with a family history of recovery are more likely to
recover than those without such a history. Natural recovery does
not seem to be related to severity of stuttering.3
The consensus now is that stuttering should be treated in the
preschool years, primarily because it becomes less tractable as
children get older. This is presumably because neural plasticity
decreases with age. Also, it is not possible to know in advance
whether an individual child will recover naturally. Early interven-
tion in the preschool years is therefore essential. Once stuttering
becomes chronic, communication can be severely impaired, with
devastating social, emotional, educational, and vocational
effects.4 5
Several treatments for early stuttering are currently
available,6 but only one, the Lidcombe programme, has been
studied with phase I and II clinical trials.7 This programme is a
behavioural treatment developed specifically for stuttering in
children of preschool age (younger than 6). Considerable
research into the programme has been conducted. Preliminary
studies have produced positive outcomes, and stuttering has
been shown to be no longer present, or remaining at very low
levels, two to seven years after treatment.8–11 The social validity
and safety of the programme have been shown.12 It does not
seem to change children’s behaviour other than speech or affect
the attachment of children and parents or use of language.13 14
Duration of treatment and its predictors have been investigated
in two independent file audits of preschool children attending
specialist clinics, one in Australia15 and one in the United
Kingdom.16
Although outcomes of the Lidcombe programme have con-
sistently been shown to be positive,8–16 a randomised controlled
trial would establish whether the effects of this intervention are
significantly and clinically greater than those of natural recovery.
We investigated the efficacy of the Lidcombe programme
through comparison with a control group that received no
formal treatment, in a pragmatic, open plan, parallel group, ran-
domised controlled trial. Our primary hypothesis was that at
nine months after randomisation, children in the treatment arm
would be stuttering less than children in the control arm. The
minimum worthwhile difference between the two arms was set at
1.0% of syllables stuttered.
Methods
The two treatment sites were the campus clinic at the University
of Canterbury (Christchurch, New Zealand) and the clinic at the
premises of the Stuttering Treatment and Research Trust (Auck-
land, New Zealand). The study population consisted of preschool
children who presented to these speech clinics for treatment. We
obtained written informed consent for all participants before
randomisation. Inclusion criteria for the trial were an age at
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recruitment of 3-6 years, stuttering as diagnosed by using stand-
ard procedures17 and at least 2% of syllables stuttered, and profi-
ciency in English for children and parents. Exclusion criteria
were treatment for stuttering during the previous 12 months and
onset of stuttering in the six months before recruitment.
The children allocated to the Lidcombe programme arm
received the treatment according to the programme manual.
Throughout the programme, parents provide verbal contingen-
cies for periods of stutter free speech and for moments of
stuttering. This occurs in conversational exchanges with the child
in the child’s natural environment. The contingencies for stutter
free speech are acknowledgment (“That was smooth”), praise
(“That was good talking”), and request for self evaluation (“Were
there any bumpy words then?”). The contingencies for
unambiguous stuttering are acknowledgment (“That was a bit
bumpy”) and request for self correction (“Can you say that
again?”). The programme is conducted under the guidance of a
speech pathologist. During the first stage of the programme, a
parent conducts the treatment for prescribed periods each day,
and parent and child visit the speech pathologist once a week.
The second stage starts when stuttering has been maintained at
a frequency of less than 1.0% of syllables stuttered over three
consecutive weeks inside and outside the clinic and is designed to
maintain those low levels. Treatment is withdrawn, and the
frequency of clinic visits decreases over a period of at least one
year, providing stuttering remains at less than 1.0% of syllables
stuttered. Details of the treatment are available in the guide for
clinicians,7 and the treatment manual is available from the web-
site of the Australian Stuttering Research Centre
(www.fhs.usyd.edu.au/ASRC).
Compliance with treatment was established by the consulting
clinicians who trained the parents in the procedures and with
sample tape recordings of parents conducting the treatments
with their children in everyday speaking environments. These
recordings confirmed that parents were administering treatment
in accordance with the treatment manual. The parents of
children in the control arm were told that they would receive the
Lidcombe programme at the end of the trial if it was shown to be
efficacious and their child was still stuttering. They were told they
could receive treatment during the trial at other clinics,
providing it was not the Lidcombe programme.
We asked parents in both arms of the trial to use audiotape
recorders to collect three samples of their child’s conversational
speech outside the clinic, before randomisation and then three,
six, and nine months after randomisation. Parents had to record
samples of their child speaking to a family member at home, to a
non-family member at home, and to a non-family member away
from home, ideally at a similar time of the day. Experienced
speech pathology observers measured the proportion of
syllables stuttered from each recording in real time by using an
electronic, button press counter and timer. One observer
assessed all recordings from the Auckland site and another from
the Christchurch site. Intrajudge and interjudge reliability was
assessed on a 5% sample of tape recordings from both sites.
The sample size required for the trial was calculated based on
a two tailed test, 80% power, level of significance 5%, and a mini-
mum clinically worthwhile difference at nine months after
randomisation of 1.0% syllables stuttered. This is the minimum
difference that a listener would be able to distinguish. On the
basis of existing data15 we assumed an exponential distribution
for the proportion of syllables stuttered. A sample size of 55 in
each group was sufficient to detect the minimum clinically
worthwhile difference. This sample size also accounted for a
modest non-compliance rate of 10%.
We used SAS, version 8.02 for Windows (SAS Institute, Cary,
NC, USA), and Stata/SE, version 8.0 for Windows (Stata Corpo-
ration, College Station, TX, USA), for our analyses.We used a two
sample t test to perform the primary comparison of difference in
the mean proportion of syllables stuttered at nine months after
randomisation. The frequency of stuttering analysed for each
child was an average of their nine month samples. We used least
squares regression to estimate treatment effect in important sub-
groups and interaction terms in the regression models to test for
heterogeneity. All analyses were by intention to treat.We used the
last observation carried forward for two participants without
follow-up tapes at nine months.
Treatment assignment and blinding
An independent central telephone randomisation service
provided by the National Health and Medical Research Council
(NHMRC) Clinical Trials Centre at the University of Sydney,
Australia, assigned each eligible and consenting participant to
the control group or treatment group. The allocation process
entailed the treatment clinician contacting the council’s clinical
trials centre by telephone, fax, or email. Treatment assignment
was conducted independently of the treating clinician.
Dynamically balanced randomisation18 was used, with stratifica-
tion by age, sex, severity of stuttering, treatment site, and family
history of recovery from stuttering. Because blinding was not
possible, observers blinded to treatment allocation assessed out-
comes. All speech recordings were de-identified and masked to
the allocated treatment.
Results
Because of difficulty with recruitment we decided to stop the trial
before we had obtained 110 participants. Recruitment began in
June 1999 and concluded in May 2003 with a total of 54 partici-
pants randomised, 31 at the University of Canterbury and 23 at
the Stuttering Treatment and Research Trust.
Participant flow and follow-up
Seven (13%) of the 54 randomised participants did not complete
the trial, and data after randomisation were not available, with all
analyses being performed on 47 participants. Reasons for not
completing the trial included major illness in the case of one
child, and families being not contactable, mainly because of relo-
cation. The figure shows the flow diagram of participants
through the trial. Comparisons of the pre-randomisation
characteristics for participants who were lost to follow-up with
those remaining in the trial showed no statistically significant
differences in severity, sex, treatment group assigned, or family
history of recovery from stuttering (table 1). The difference in
age reached significance, however, with the participants
withdrawing being on average nine months older (P = 0.015, two
sample t test). Two participants had data for analysis available for
only six months and seven months, respectively, after
randomisation. The median time from randomisation to final
follow-up was 11 months in the control arm and nine months in
the treatment arm. Five (9%) protocol violations occurred: four
children in the control arm received some Lidcombe
programme treatment and one child allocated to the
intervention group received only three weeks of treatment
(figure). Three participants allocated to the control arm received
other treatment. Two participants received Easy-does-it,19 and
one received some components of the Lidcombe programme on
an ad hoc basis.
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Speech samples
We collected 517 speech samples for analysis. For each child at
each of the measurement occasions in the trial, an average of 2.3
(range 1-6) speech samples were available for analysis. The
speech samples obtained had a mean duration of 433 syllables
(SD 12). We obtained intraclass correlations of r= 0.99 for both
intrajudge and interjudge reliability.
Analysis
Of the 54 participants recruited to the study, 29 were allocated to
the treatment group and 25 to the control group. A comparison
of pre-randomisation characteristics by treatment group shows
the groups to be similar (table 2). Table 3 shows that severity of
stuttering measured by proportion of syllables stuttered was
similar in the two groups before randomisation.However, at nine
months after randomisation, we noted a difference of 2.3% of
syllables stuttered between the treatment group and the control
group (95% confidence interval 0.8% to 3.9%, P = 0.003). The
results were similar after adjustment for treatment site, baseline
severity, age, sex, and family history of recovery from stuttering.
We conducted an exploratory analysis of the proportion of
children with less than 1.0% syllables stuttered at nine months
after randomisation. The proportion was higher in the
Lidcombe arm than in the control arm when adjusted for the
baseline severity score in a logistic regression model (table 4).
Table 5 shows estimates of effect size within subgroups stratified
at baseline. The only test of heterogeneity to reach significance
shows a larger effect of treatment for those children without a
family history of recovery from stuttering than for children with
a history. Effect sizes seemed to be consistent in all other impor-
tant subgroups, with the possible exception of the treatment site.
However, the control group doing better in Auckland than in
Christchurch could explain this possible difference.
Discussion
After nine months, the reduction of stuttering in the Lidcombe
programme group was significantly and clinically greater than
natural recovery. The estimated effect size of 2.3% of syllables
stuttered is more than double the minimum clinically
worthwhile difference specified in the trial protocol. At nine
months, the control group had reduced their frequency of
stuttering by an average of 43%, presumably from a combination
of natural recovery and the ad hoc treatment given to some of
the participants. However, only 15% of children in the control
arm attained a minimal level of stuttering as defined in the trial
protocol. In contrast, the treatment group had reduced their
stuttering by 77%, resulting in a mean frequency of 1.5%
syllables stuttered. Most children in the Lidcombe programme
group were still in the second stage of the programme at the
nine month follow-up point.
Children referred for treatment of stuttering (n=134)
Randomisation
Lidcombe programme* (n=29)
Exclusions:
 Ineligible (n=29)
 Declined (n=27)
 Not recommended for treatment (n=18)
 Other (n=6)
Relocated/not contactable
 (n=2)
* One participant randomised to the Lidcombe programme only received
   treatment for three weeks and four participants randomised to control
   received some Lidcombe treatment
† Six month follow-up data were used for one participant and seven
   month data for another, as nine month follow-up data were not
   obtained
Control group* (n=25)
Included in 9 month
post-randomisation
assessment † (n=27)
Included in 9 month
post-randomisation
assessment (n=20)
Relocated/not contactable
 (n=3)
Major illness (n=1)
Relocated overseas (n=1)
Flow of participants through the trial
Table 1 Comparison of baseline characteristics of participants lost to
follow-up with participants remaining in study. Values are numbers
(percentages) of subjects unless otherwise indicated
Lost to follow up
(n=7)
Remaining in study
(n=47)
P value for difference
(Fisher’s exact test)
% syllables stuttered:
2-5 3 (43) 15 (32) 0.7
>5 4 (57) 32 (68)
Female 2 (29) 10 (21) 0.6
Family history of
recovery
3 (43) 21 (45) 0.9
Treatment group:
Lidcombe
programme
2 (29) 27 (57) 0.2
Control 5 (71) 20 (43)
Mean age in years
(SD)
4.7 (0.7) 3.9 (0.6) 0.015 (two sample t
test)
Table 2 Baseline characteristics of all participants. Values are numbers (%)
of participants unless otherwise indicated
Lidcombe programme
(n=29)
Control (n=25) Total (n=54)
Age in years:
3-4 17 (59) 12 (48) 29 (54)
4-5 9 (31) 12 (48) 21 (39)
5-6 3 (10) 1 (4) 4 (7)
% syllables stuttered:
2-5 9 (31) 9 (36) 18 (33)
>5 20 (69) 16 (64) 36 (67)
Female 7 (24) 5 (20) 12 (22)
Family history of recovery 13 (45) 11 (44) 24 (44)
Table 3 Severity of stuttering (% syllables stuttered) before randomisation
and at nine months. Values are means with standard deviations unless
otherwise indicated
Lidcombe
programme (n=27)
Control (n=20) Difference in %
syllables stuttered at
nine months (95%
CI, P value)
Before randomisation 6.4 (4.3) 6.8 (4.9) 2.3
(0.8 to 3.9, P=0.003)At nine months 1.5 (1.4) 3.9 (3.5)
Table 4 Numbers (percentages) of participants achieving less than 1.0% of
syllables stuttered at nine months
% syllables stuttered
Lidcombe
programme (n=27)
Control group
(n=20) Odds ratio (95% CI)
<1.0 14 (52) 3 (15) 0.13
(0.03 to 0.63, P=0.011)≥1.0 13 (48) 17 (85)
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Study limitations
Our study has some limitations that should be acknowledged,
but these are not sufficient to alter the main conclusion. The
achieved sample size was only half that proposed, and seven of
the 54 randomised participants did not complete the trial. These
participants were older than the participants who did complete
the trial, by an average of nine months. However, this difference
in age is unlikely to have had an important effect on the results
of the trial because the number of participants lost to follow-up
is small, and there is no evidence to show that age is correlated
with the proportion of syllables stuttered at nine months after
randomisation for the participants who completed the trial.
Another limitation is that the post-randomisation period
lasted nine months only. Ideally it should have been longer than
this so that the children in the treatment group could have com-
pleted the second stage of the treatment programme and the
children in the control group would have had more time to
recover naturally. However, retaining a control group of stutter-
ing children for longer than nine months is very difficult. Initially,
follow-up was for 12 months, but this was reduced because par-
ents of children allocated to the control group were unwilling to
wait that long to receive treatment for their child.
Conclusions
Given its apparent efficacy, then, numerous reasons support
implementing the Lidcombe programme in the preschool years.
Although several children presenting at a clinic with early
stuttering may recover without treatment, identifying these chil-
dren in advance is not possible. Waiting for an extended period
to see if natural recovery occurs is not acceptable because it
seems that the Lidcombe programme is less efficacious once
children move into the school age years.20 In addition, delaying
treatment until the school age years is not a viable option
because of the negative social and cognitive consequences of
stuttering at this age.21 If the disorder persists into the school age
years a child is exposed to the unacceptable risk of experiencing
the disabling effects of chronic and intractable stuttering
throughout life.
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Table 5 Estimates of effect size within subgroups
Subgroup
No of
participants
(n=47)
Effect size as % syllables
stuttered (95% CI)
P value for
heterogeneity*
Treatment site:
Auckland 22 1.1 (−0.6 to 2.8) 0.15
Christchurch 25 3.3 (0.9 to 5.8)
Sex:
Male 37 2.4 (0.6 to 4.2) 0.8
Female 10 2.0 (−1.6 to 5.5)
Age in years:
<4 28 2.4 (0.1 to 4.7) 0.9
≥4 19 2.3 (0.4 to 4.2)
Family history of recovery:
No 26 3.8 (1.5 to 6.2) 0.027
Yes 21 0.5 (−1.6 to 2.7)
Baseline severity in %
syllables stuttered:
<5 19 2.1 (0.2 to 4.0) 0.6
≥5 28 2.7 (0.5 to 4.9)
*Obtained from a test of interaction in a least squares regression model.
What is already known on this topic
Chronic stuttering in adulthood is intractable and has
serious disabling effects
The consensus is that early intervention in the preschool
years is necessary
Randomised controlled trial evidence for the efficacy of
early stuttering intervention has not been obtained
What this study adds
The Lidcombe programme, an early intervention for
stuttering, is significantly and clinically more efficacious
than no formal programme in treating stuttering in
preschool children
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